• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake.

作者信息

Young A A, Gedulin B R, Rink T J

机构信息

Amylin Pharmaceuticals, San Diego CA 92121, USA.

出版信息

Metabolism. 1996 Jan;45(1):1-3. doi: 10.1016/s0026-0495(96)90192-4.

DOI:10.1016/s0026-0495(96)90192-4
PMID:8544764
Abstract

Several peptides have been proposed as regulators of nutrient release from the stomach and subsequent uptake from the gut. Using a phenol red gavage method, we compared the potencies of subcutaneously preinjected amylin, glucagon-like peptide-1 (7-36)amide (GLP-1), cholecystokinin octapeptide (CCK-8), gastric inhibitory peptide (GIP), glucagon, and pancreatic peptide on slowing the release of an acaloric gel from rat stomach. The latter three peptides did not fully inhibit gastric emptying at subcutaneous doses up to 100 micrograms. Amylin, GLP-1, and CCK-8 fully inhibited gastric emptying, with ED50s of 0.42 +/- 0.07, 6.1 +/- 0.12, and 8.5 +/- 0.20 nmol/kg +/- SE of log, respectively.

摘要

相似文献

1
Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake.
Metabolism. 1996 Jan;45(1):1-3. doi: 10.1016/s0026-0495(96)90192-4.
2
Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.胰高血糖素样肽-1(7-36)酰胺与胃抑制多肽或胆囊收缩素对离体灌注大鼠胰腺胰岛素和胰高血糖素分泌的相互作用。
Metabolism. 1992 Apr;41(4):359-63. doi: 10.1016/0026-0495(92)90068-l.
3
Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue.使用一种新型生长抑素(SRIF)拮抗剂类似物研究生长抑素在胃抑制肽(GIP)、胰高血糖素样肽-1(GLP-1)、胰淀素和肾上腺髓质素对胃酸分泌的抑制作用中的参与情况。
Br J Pharmacol. 1998 Nov;125(5):1081-7. doi: 10.1038/sj.bjp.0702160.
4
Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.胰高血糖素样肽-(7-36)酰胺和胰淀素对大鼠肺循环的血管舒张作用。
Regul Pept. 2001 Dec 15;102(2-3):81-6. doi: 10.1016/s0167-0115(01)00300-7.
5
Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.胆囊收缩素、胃抑制多肽和胰高血糖素样肽-1在短期培养的犬分离胰岛灌注期间的促胰岛素分泌作用
Regul Pept. 1995 Dec 7;60(1):61-7. doi: 10.1016/0167-0115(95)00122-4.
6
Inhibition of gastric emptying.胃排空抑制
Adv Pharmacol. 2005;52:99-121. doi: 10.1016/S1054-3589(05)52006-4.
7
Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.胰高血糖素样肽-1(7-36)酰胺、葡萄糖依赖性促胰岛素多肽及胆囊收缩素-8对离体灌注大鼠胰腺的启动效应
Biochim Biophys Acta. 1991 Feb 19;1091(3):356-63. doi: 10.1016/0167-4889(91)90200-h.
8
Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.静脉注射胰高血糖素样肽-1可有效抑制大鼠的食物摄入、假饲和胃排空。
Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1695-706. doi: 10.1152/ajpregu.00870.2004. Epub 2005 Feb 17.
9
Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.阿卡波糖对胃排空的抑制作用与胰高血糖素样肽-1反应相关,并伴有胆囊收缩素的释放。
Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G752-63. doi: 10.1152/ajpgi.2001.281.3.G752.
10
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?胰高血糖素样肽-1 对胃排空、食欲和食物摄入的作用是否涉及到在人体中胰淀素的释放?
J Clin Endocrinol Metab. 2010 May;95(5):2367-75. doi: 10.1210/jc.2009-2133. Epub 2010 Mar 1.

引用本文的文献

1
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity.胰淀素:从作用机制到在糖尿病和肥胖症中的未来临床潜力
Diabetes Ther. 2025 Jun;16(6):1207-1227. doi: 10.1007/s13300-025-01733-8. Epub 2025 May 7.
2
Intranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice.鼻内注射普兰林肽对小鼠食物摄入量和胃排空的影响与腹腔注射效果相当。
Endocrine. 2025 Apr 2. doi: 10.1007/s12020-025-04220-z.
3
Mediators of Amylin Action in Metabolic Control.代谢控制中胰淀素作用的介质
J Clin Med. 2022 Apr 15;11(8):2207. doi: 10.3390/jcm11082207.
4
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat.胰淀素与降钙素:减轻体重和肝脏脂肪的潜在治疗策略。
Front Endocrinol (Lausanne). 2021 Jan 8;11:617400. doi: 10.3389/fendo.2020.617400. eCollection 2020.
5
Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance.后脑二肽基肽酶-IV抑制可改善血糖控制并促进负能量平衡。
Physiol Behav. 2017 May 1;173:9-14. doi: 10.1016/j.physbeh.2017.01.038. Epub 2017 Jan 22.
6
Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.病程对普兰林肽治疗1型糖尿病疗效的影响:三项临床试验的事后分析
Adv Ther. 2016 May;33(5):848-61. doi: 10.1007/s12325-016-0326-5. Epub 2016 Apr 12.
7
Amylin-mediated control of glycemia, energy balance, and cognition.胰淀素介导的血糖、能量平衡及认知调控。
Physiol Behav. 2016 Aug 1;162:130-40. doi: 10.1016/j.physbeh.2016.02.034. Epub 2016 Feb 27.
8
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?肥胖相关合并症的改善是否取决于肠道激素分泌的改变?
World J Gastroenterol. 2014 Nov 28;20(44):16649-64. doi: 10.3748/wjg.v20.i44.16649.
9
GLP-1: benefits beyond pancreas.GLP-1:超越胰腺的益处。
J Endocrinol Invest. 2014 Dec;37(12):1143-53. doi: 10.1007/s40618-014-0137-y. Epub 2014 Aug 9.
10
Simultaneous monitoring of insulin and islet amyloid polypeptide secretion from islets of Langerhans on a microfluidic device.在微流控装置上同时监测胰岛中胰岛素和胰岛淀粉样多肽的分泌。
Anal Chem. 2013 Aug 20;85(16):7919-25. doi: 10.1021/ac401625g. Epub 2013 Jul 30.